Third-generation oral contraceptives are an association of low-dose ethinyl estradiol and potent testosterone-derived progestins, developed in order to improve general and vascular tolerance.

There are two versions of DMPA currently available in the USA – a formulation intended for IM administration (150 mg/ml) and a formulation intended for SQ injection (104 mg/0.65 ml). DMPA is a ...